c‐MYC, which has the overall structure and organization of genes and transcripts similar to MYCN [36, 37], may be responsible for partial response to ceftriaxone of tumor cells expressing the c‐MYC rather than MYCN. The gene discussed is MYCN; the disease is neoplasm.